FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2076753835> ?p ?o ?g. }

• W2076753835 endingPage "246" @default.
• W2076753835 startingPage "243" @default.
• W2076753835 abstract "The UK Prospective Diabetes Study (UKPDS) confirmed that intensive therapy resulting in optimal glycaemic control (HbA1C7%) reduces the risk of microvascular complications in patients with type 2 diabetes. The understanding that type 2 diabetes is a progressive disease has resulted in many patients being converted from tablets to insulin following secondary failure of hypoglycaemic agents. Recognising the need for early intervention, increasing numbers of patients are being referred from primary care for initiation of insulin therapy. To cope with this increase in demand, group education insulin starter groups were introduced at our centre in 1999. The aim of this study was to retrospectively compare the one-year outcome in terms of metabolic and treatment satisfaction parameters for all patients with type 2 diabetes who were converted to insulin conventionally in a one-to-one setting with a diabetes specialist nurse (1997–1998) or via group education insulin starter groups (1999–2000). Records of consecutive patients with type 2 diabetes, converted to insulin during 1997–1998 (conventional one-to-one group) and 1999–2000 (insulin starter group) were audited for baseline parameters and one-year follow-up outcomes. Treatment satisfaction was measured using the Diabetes Treatment Satisfaction Questionnaire (DTSQ). Both conventional one-to-one (n=64) and insulin starter group (n=69) therapy were equally matched for age, duration of diabetes and initial weight. Initial glycaemic control was significantly higher with one-to-one teaching compared with group therapy (fructosamine 479±99µmol/L vs 439±82µmol/L respectively, p=0.01). At one year, glycaemic control was similar for both groups (one-to-one 381±72µmol/L vs insulin starter group 397±76µmol/L, p=NS). Similar numbers of patients in both groups achieved target glycaemic control of <350µmol/L fructosamine. General treatment satisfaction in the insulin starter group setting (30.4±7) was significantly greater than one-to-one teaching (26.9±8, p=0.001), out of a maximum score of 36, measured using the DTSQ. In conclusion, conversion to insulin can be successfully achieved through group sessions, with patients reporting greater treatment satisfaction than those receiving one-to-one teaching. Copyright © 2003 John Wiley & Sons, Ltd." @default.
• W2076753835 created "2016-06-24" @default.
• W2076753835 creator A5015860518 @default.
• W2076753835 creator A5028339415 @default.
• W2076753835 creator A5058132925 @default.
• W2076753835 creator A5082509084 @default.
• W2076753835 date "2003-01-01" @default.
• W2076753835 modified "2023-09-27" @default.
• W2076753835 title "Treatment satisfaction and metabolic outcome in patients with type 2 diabetes starting insulin: one-to-onevs group therapy" @default.
• W2076753835 cites W1964413807 @default.
• W2076753835 cites W2028937092 @default.
• W2076753835 cites W2069341139 @default.
• W2076753835 cites W2156160269 @default.
• W2076753835 cites W2337454357 @default.
• W2076753835 doi "https://doi.org/10.1002/pdi.515" @default.
• W2076753835 hasPublicationYear "2003" @default.
• W2076753835 type Work @default.
• W2076753835 sameAs 2076753835 @default.
• W2076753835 citedByCount "4" @default.
• W2076753835 countsByYear W20767538352015 @default.
• W2076753835 countsByYear W20767538352016 @default.
• W2076753835 countsByYear W20767538352017 @default.
• W2076753835 crossrefType "journal-article" @default.
• W2076753835 hasAuthorship W2076753835A5015860518 @default.
• W2076753835 hasAuthorship W2076753835A5028339415 @default.
• W2076753835 hasAuthorship W2076753835A5058132925 @default.
• W2076753835 hasAuthorship W2076753835A5082509084 @default.
• W2076753835 hasBestOaLocation W20767538351 @default.
• W2076753835 hasConcept C126322002 @default.
• W2076753835 hasConcept C134018914 @default.
• W2076753835 hasConcept C141071460 @default.
• W2076753835 hasConcept C2777180221 @default.
• W2076753835 hasConcept C2778804033 @default.
• W2076753835 hasConcept C2779306644 @default.
• W2076753835 hasConcept C2779920387 @default.
• W2076753835 hasConcept C2781357877 @default.
• W2076753835 hasConcept C555293320 @default.
• W2076753835 hasConcept C70818257 @default.
• W2076753835 hasConcept C71924100 @default.
• W2076753835 hasConceptScore W2076753835C126322002 @default.
• W2076753835 hasConceptScore W2076753835C134018914 @default.
• W2076753835 hasConceptScore W2076753835C141071460 @default.
• W2076753835 hasConceptScore W2076753835C2777180221 @default.
• W2076753835 hasConceptScore W2076753835C2778804033 @default.
• W2076753835 hasConceptScore W2076753835C2779306644 @default.
• W2076753835 hasConceptScore W2076753835C2779920387 @default.
• W2076753835 hasConceptScore W2076753835C2781357877 @default.
• W2076753835 hasConceptScore W2076753835C555293320 @default.
• W2076753835 hasConceptScore W2076753835C70818257 @default.
• W2076753835 hasConceptScore W2076753835C71924100 @default.
• W2076753835 hasIssue "7" @default.
• W2076753835 hasLocation W20767538351 @default.
• W2076753835 hasOpenAccess W2076753835 @default.
• W2076753835 hasPrimaryLocation W20767538351 @default.
• W2076753835 hasRelatedWork W110977339 @default.
• W2076753835 hasRelatedWork W1964413807 @default.
• W2076753835 hasRelatedWork W1978287097 @default.
• W2076753835 hasRelatedWork W1985971467 @default.
• W2076753835 hasRelatedWork W2003473705 @default.
• W2076753835 hasRelatedWork W2035694005 @default.
• W2076753835 hasRelatedWork W2036805550 @default.
• W2076753835 hasRelatedWork W2408872980 @default.
• W2076753835 hasRelatedWork W2411063883 @default.
• W2076753835 hasRelatedWork W2475008142 @default.
• W2076753835 hasVolume "20" @default.
• W2076753835 isParatext "false" @default.
• W2076753835 isRetracted "false" @default.
• W2076753835 magId "2076753835" @default.
• W2076753835 workType "article" @default.